USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medmix Switzerland Ag

USPTO PatentsView assignee record - 50 granted patents across 23 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B05C (APPARATUS FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL).

50
Total patents granted
23
CPC technology areas
16.7
Avg claims per patent
-
5-year filing velocity

The verdict

medmix holds 50 US patents across 23 technology areas, rank #6,729 of 50,000 tracked assignees.

#6,729
of 50,000 US assignees by volume
Top 3%
by Innovation Score (60.6/100)
16.7
avg claims per patent

Portfolio overview

Medmix Switzerland Ag has been granted 50 US utility patents between 2022 and 2025, placing Medmix Switzerland Ag at rank #6,729 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in B05C (APPARATUS FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL). As a Foreign Corporation, Medmix Switzerland Ag is one of the more focused assignees in the PatentsView dataset. By volume, medmix sits between Wenzhou University (50 patents, rank #6,725) and AGFA Graphics Nv (49 patents, rank #6,733) - the closest US assignees by grant volume. The composite Innovation Score of 60.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 50 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medmix Switzerland Ag's 16.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 23 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medmix Switzerland Ag against peers pursuing similar technology classes.

Who files at Medmix's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medmix holds 50 patents at rank #6,729, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medmix

By rank, the assignees closest to #6,729 in granted patent volume.

Leaders in B05C (Apparatus FOR Applying Fluent Materials TO Surfaces)

Other assignees with the most granted patents in Medmix's primary technology class.

medmix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

510152025 2022202320242025 9
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Medmix Switzerland Ag patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 10 20.0%
2023 11 22.0%
2024 20 40.0%
2025 9 18.0%

Which technologies does Medmix Switzerland Ag patent most?

Top 15 of 23 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard

Where it ranks

Overall rank by patents

#6,729

Across all tracked assignees

Innovation Score

60.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medmix Switzerland Ag hold?
Medmix Switzerland Ag holds 50 US granted patents filed between 2022 and 2025, spanning 23 technology areas.
What is Medmix Switzerland Ag's Innovation Score?
Medmix Switzerland Ag has an Innovation Score of 60.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Medmix Switzerland Ag focus on?
Medmix Switzerland Ag's top technology area is B05C (APPARATUS FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL) with 22 patents. The company has filed patents in 23 CPC subclasses total.
Is Medmix Switzerland Ag's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Medmix Switzerland Ag.
What does claim depth mean for Medmix Switzerland Ag's patents?
Medmix Switzerland Ag's patents average 16.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the Medmix Switzerland Ag patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

medmix's 50 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - medmix ranks #6,729 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in B05C - see who else leads that technology area. B05C leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.